Kinnate Biopharma Inc.

NASDAQ:KNTE

2.65 (USD) • At close April 2, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202320222021202020192018
Assets:
Current Assets:
Cash & Cash Equivalents 56.99829.261116.096365.46276.4536.999
Short Term Investments 97.036172.214103.36231.39800
Cash and Short Term Investments 154.034201.475219.458396.8676.4536.999
Net Receivables 00000.9730
Inventory 000000
Other Current Assets 4.1433.6375.6393.3430.0250
Total Current Assets 158.177230.837258.69400.20377.4518.077
Non-Current Assets:
Property, Plant & Equipment, Net 4.766.4480.9560.3680.1540
Goodwill 000000
Intangible Assets 000000
Goodwill and Intangible Assets 000000
Long Term Investments 10.6339.139105.449000
Tax Assets 000000
Other Non-Current Assets 0.0382.4021.769000
Total Non-Current Assets 15.42847.989108.1740.3680.1540
Total Assets 173.605278.826366.864400.57177.6058.077
Liabilities & Equity:
Current Liabilities:
Account Payables 2.0312.973.1483.940.9560.442
Short Term Debt 0.8920.9910000
Tax Payables 000000
Deferred Revenue 000000
Other Current Liabilities 9.07213.2069.2393.3640.9890.025
Total Current Liabilities 11.99517.16712.3877.3041.9450.467
Non-Current Liabilities:
Long Term Debt 2.2833.1910000
Deferred Revenue Non-Current 000000
Deferred Tax Liabilities Non-Current 000000
Other Non-Current Liabilities 000000
Total Non-Current Liabilities 2.2833.19135093.1460
Total Liabilities 14.27820.35812.3877.30495.0910.467
Equity:
Preferred Stock 000400.57193.1460
Common Stock 0.0050.0040.0040.00400
Retained Earnings -372.012-259.363-143.092-53.329-17.568-7.63
Accumulated Other Comprehensive Income/Loss -0.012-1.41-0.524-0.00900
Other Total Stockholders Equity 531.346484.237463.089446.601-93.06415.24
Total Shareholders Equity 159.327223.468319.477393.267-17.4867.61
Total Equity 159.327258.468354.477393.267-17.4867.61
Total Liabilities & Shareholders Equity 173.605278.826366.864400.57177.6058.077